Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study.
Saved in:
| Title: | Drug interactions between probe drugs dolutegravir (DTG), midazolam (MDZ) and digoxin (DIG) with escalating doses of rifampicin (RIF): DORIS study. |
|---|---|
| Authors: | Dickinson, L.1 (AUTHOR), Singh, Y.2 (AUTHOR), Semakula, J.3 (AUTHOR), Chodacki, P.2 (AUTHOR), Kassim, S.2 (AUTHOR), Namuddu, D.3 (AUTHOR), Sihlangu, M.2 (AUTHOR), Read, L.4 (AUTHOR), Else, L.1 (AUTHOR), Reynolds, H.1 (AUTHOR), Thompson, B.1 (AUTHOR), Monk, R.1 (AUTHOR), Lawson, A.5 (AUTHOR), Ayre, C.5 (AUTHOR), Read, J.4 (AUTHOR), Wang, D.4 (AUTHOR), Waitt, C.1,3 (AUTHOR), Orrell, C.2,6 (AUTHOR), Khoo, S.1 (AUTHOR) |
| Source: | British Journal of Clinical Pharmacology. Sep2025 Supplement 1, Vol. 91, p11-11. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 03065251 |
|---|---|
| DOI: | 10.1002/bcp.70214 |
